Table 1 Number of patients per site and characteristics of enrolled TB DOTS patients.

From: Patterns and predictors of co-morbidities in Tuberculosis: A cross-sectional study in the Philippines

 

Metro Manila region (N = 338)

Negros Occidental region (N = 299)

Total (N = 637)

p-value1

Centre

San Nicolas

108

   

Pedro Gil

102

   

San Lazaro Hospital

128

   

Bago City

 

222

  

Valladolid

 

77

  

Sex

Female

97 (28.7)

94 (31.4)

191 (30.0)

0.488

Male

241 (71.3)

205 (68.6)

446 (70.0)

 

Age (years)

18–40

183 (54.1)

89 (29.8)

272 (42.7)

<0.001

41–65

127 (37.6)

154 (51.5)

281 (44.1)

 

>65

28 (8.3)

56 (18.7)

84 (13.2)

 

Household size

mean (SD)

4.7 (3.1)

4.7 (2.2)

4.7 (2.7)

0.972

Marital status

Single

171 (50.6)

87 (29.1)

258 (40.5)

<0.001

Married

132 (39.1)

165 (55.2)

297 (46.6)

 

Divorced/separated

8 (2.4)

6 (2.0)

14 (2.2)

 

Widowed

27 (8.0)

41 (13.7)

68 (10.7)

 

Highest level of education obtained

Primary

63 (18.6)

155 (51.8)

218 (34.2)

<0.001

Secondary

147 (43.5)

104 (34.8)

251 (39.4)

 

Tertiary

120 (35.5)

27 (9.0)

147 (23.1)

 

Vocational

8 (2.4)

13 (4.3)

21 (3.3)

 

Health insurance2

No

145 (45.7)

98 (33.2)

243 (39.7)

0.002

Yes

172 (54.3)

197 (66.8)

369 (60.3)

 

Time to health clinic (minutes), median (range)

15 (0–300)

6 (1–120)

10 (0–300)

<0.001

Smoking status

No or Ex

304 (89.9)

209 (69.9)

513 (80.5)

<0.001

Yes

34 (10.1)

90 (30.1)

124 (19.5)

 

Alcohol consumption

Daily

25 (7.4)

92 (30.8)

117 (18.4)

<0.001

Weekly or monthly

78 (23.1)

61 (20.4)

139 (21.8)

 

Rarely/Never

235 (69.5)

146 (48.8)

381 (59.8)

 

Weight change last 3–6 months3

No change

70 (20.8)

32 (10.7)

102 (16.0)

<0.001

Increase

73 (21.7)

18 (6.0)

91 (14.3)

 

Decrease

194 (57.6)

249 (83.3)

443 (69.7)

 

Food intake last 1 month3

No change

196 (58.2)

43 (14.4)

239 (37.6)

<0.001

Increase

66 (19.6)

79 (26.4)

145 (22.8)

 

Moderate decrease

65 (19.3)

98 (32.8)

163 (25.6)

 

Severe decrease

10 (3.0)

79 (26.4)

89 (14.0)

 

Household Food security score

Secure

218 (64.5)

108 (36.1)

326 (51.2)

<0.001

Moderate insecurity

69 (20.4)

98 (32.8)

167 (26.2)

 

Severe insecurity

51 (15.1)

93 (31.1)

144 (22.6)

 

Multi-drug resistant TB

No

305 (90.2)

299 (100.0)

604 (94.8)

<0.001

Yes

33 (9.8)

0 (0)

33 (5.2)

 

Previous TB4

New case

206 (61.5)

187 (62.8)

393 (62.1)

0.806

Relapse case

129 (38.5)

111 (37.3)

240 (37.9)

 

Bacteriologically confirmed TB5

No

198 (60.2)

210 (70.2)

408 (65.0)

0.009

Yes

131 (39.8)

89 (29.8)

220 (35.0)

 

Treatment phase6

Intensive

199 (58.9)

133 (44.5)

332 (52.1)

<0.001

Continuation

139 (41.1)

166 (55.5)

305 (47.9)

 
  1. Data are n (%) of non-missing values for each characteristic, unless otherwise indicated as mean (SD) or median (range).
  2. 1p-value from Fishers exact test for categorical variables, t-test to compare means or Wilcoxon rank sum test to compare medians.
  3. 221 missing values in Metro Manila region and 4 missing values in Negros Occidental region.
  4. 31 missing value in Metro Manila region.
  5. 43 missing value in Metro Manila and 1 missing value in Negros Occidental region.
  6. 59 missing values in Metro Manila region.
  7. 6Intensive treatment phase, unless extended, is the first 2 months of the 6 month standard TB-DOTS shorter regimen comprising isoniazid, rifampicin, pyrazinamide and ethambutol, followed by continuation phase comprising isoniazid and rifampicin only. The intensive phase of the 9/12 months WHO shorter regimen for multi-drug resistant TB is the first 4 months (unless extended) comprising kanamycin, moxifloxacin, prothionamide, clofazimine, pyrazinamide and high dose isoniazid and ethambutol followed by continuation phase comprising moxifloxacin, clofazimine, pyrazinamide and ethambutol only.
Back to article page